prof. Sylvie Rottey
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 2
9000 Gent - Sylvie.Rottey@UGent.be
- ORCID iD
-
0000-0003-2060-3725
Show
Sort by
-
- Conference Paper
- open access
DRUG DEVELOPMENT FROM BENCH TO BEDSIDE @ UZGENT
(2020) -
Radiologic extranodal extension and outcome in cN + D TNM-8 stage I human papillomavirus-mediated oropharyngeal cancer : in regard to Billfalk-Kelly et al.
-
Policies influencing access to new targeted oncologic drugs in Ecuadorian hospitals : an interrupted time series analysis
-
Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results
-
Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results
-
Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy
(2019) EAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 41(10). p.3594-3603 -
Prostate protein n-glycosylation profiling by means of DNA sequencer-assisted fluorophore-assisted carbohydrate electrophoresis
-
- Journal Article
- A1
- open access
N-Linked glycosylation and near-infrared spectroscopy in the diagnosis of prostate cancer
-
Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma
-
Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer